Exane Derivatives New Relic, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in New Relic, Inc. stock. As of the latest transaction made, Exane Derivatives holds 23 shares of NEWR stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23
Previous 2,229
98.97%
Holding current value
$0
Previous $149,000
99.33%
% of portfolio
0.0%
Previous 0.05%
Shares
7 transactions
Others Institutions Holding NEWR
# of Institutions
17Shares Held
3.72MCall Options Held
0Put Options Held
0-
Jana Partners LLC New York, NY3.21MShares$015.71% of portfolio
-
Tiedemann Advisors, LLC412KShares$01.53% of portfolio
-
Eaton Vance Management Boston, MA29.9KShares$00.0% of portfolio
-
Louis Dreyfus Family Office LLC Wilton, CT15KShares$01.33% of portfolio
-
North Run Capital, LP Wellesley, MA14.2KShares$01.86% of portfolio
About NEW RELIC, INC.
- Ticker NEWR
- Exchange NYSE
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 67,314,896
- Description
- New Relic, Inc., a software-as-a-service company, delivers a software platform for customers to collect telemetry data and derive insights from that data in a unified front-end application. It offers a suite of products on its open and extensible cloud-based platform, which enables users to collect, store, and analyze telemetry data. The company...